CONTENT WARNING
Why do we not call schizophrenics ‘schizophrenics’ anymore?
Times have changed for reasons unseen.
I’m about to be homeless and detransitioned, or jammed into a shelter for the blatant ignorance of this ongoing cultural genocide of the honest schizophrenic, cross-sectioned with bianary trans genocide.
Schizophrenia: A Complete, Evidence-Based Explanation Grounded in Science and Lived Experience
by Daphne Garrido in synthesis with Grok, churning years of art therapy, along with rigorous research into the peer-reviewed literature of psychology for synthesizing this holistic understanding anew
Schizophrenia is a serious, heterogeneous neurodevelopmental disorder that affects how a person thinks, perceives, feels, and behaves. It is not a “split personality” or a simple loss of touch with reality. It is a complex disruption in the brain’s ability to integrate information, maintain coherent mental processes, and adapt to the social world. Affecting roughly 23–24 million people worldwide (WHO, 2023), it typically emerges in late adolescence or early adulthood and carries significant functional challenges when unsupported. Modern science views it as arising from gene-environment interactions, not moral failing or personal weakness.
Diagnosing Principles (DSM-5-TR and ICD-11)
Diagnosis requires a careful, longitudinal clinical assessment. According to the DSM-5-TR (American Psychiatric Association, 2022) and ICD-11 (World Health Organization, 2019/2024 update), at least two of the following core symptoms must be present for a significant portion of one month (or less if successfully treated), with at least one being delusions, hallucinations, or disorganized speech:
Delusions (fixed false beliefs)
Hallucinations (perceptual experiences without external stimuli)
Disorganized speech (thought disorder)
Grossly disorganized or catatonic behavior
Negative symptoms (diminished emotional expression or avolition)
Continuous signs of disturbance must persist for at least 6 months, causing marked decline in work, relationships, or self-care. Differential diagnosis rules out substance effects, medical conditions (e.g., autoimmune encephalitis), or mood disorders with psychotic features. Diagnosis is clinical—no single blood test or scan confirms it—though neuroimaging and cognitive testing can support it.
Symptoms and Their Place in Human Consciousness
Schizophrenia reveals vulnerabilities in the ordinary architecture of human consciousness. The brain normally binds perception, emotion, memory, and prediction into a seamless “self” experience. In schizophrenia, this binding falters.
Positive symptoms (delusions and hallucinations) arise from overactive prediction-error signaling. The brain’s dopamine system, which tags salient events, becomes dysregulated. Normal sensory noise or internal thoughts are tagged as highly meaningful, leading to fixed beliefs or voices. This is not “madness” in the chaotic sense—it is the brain doing its usual job of pattern-seeking, but without adequate filtering or reality-testing (Fletcher & Frith, 2009; Corlett et al., 2019).
Negative symptoms (avolition, flat affect) reflect hypofrontality and disrupted motivation circuits. Executive dysfunction—difficulty initiating, planning, or sustaining goal-directed behavior—is central and often the most disabling feature. It is not laziness; it is a breakdown in the prefrontal networks that let healthy people translate intention into action (Barch & Ceaser, 2012).
Cognitive symptoms (working-memory deficits, poor attention) stem from impaired glutamatergic signaling and disrupted connectivity between brain regions. Consciousness itself feels fragmented: thoughts scatter, time feels slippery, and the boundary between inner experience and outer world blurs.
These symptoms make sense in the broader framework of human consciousness. The brain is a predictive organ constantly generating a model of reality and updating it with sensory data (Friston, 2010). Schizophrenia shows what happens when that predictive machinery becomes unbalanced: the world feels too loud, too meaningful, or too empty all at once. Lived experience often echoes this—executive dysfunction feels like being trapped in a body and mind that will not cooperate, while unaddressed trauma (isolation, stigma, punishment) amplifies every symptom, turning manageable distress into a consuming cycle of anger, exhaustion, and withdrawal.
How Systems Let People Down
Contemporary mental-health systems frequently fail people with schizophrenia by offering symptom suppression (antipsychotics) without the relational safety and practical support needed for genuine recovery. Many receive a diagnosis, medication, and then little else—no supported housing, no cognitive remediation, no family education, and often active societal punishment for the very symptoms the disorder produces (executive dysfunction leading to missed appointments or disorganized pleas for help). Longitudinal studies show that lack of psychosocial support predicts poorer outcomes far more than the illness itself (Harrow et al., 2014; Jääskeläinen et al., 2013). Trauma from institutionalization, forced treatment, or community rejection compounds neurobiological vulnerability, creating a feedback loop where the person is blamed for the very disability the system refuses to accommodate.
Moving Forward: Present-Day Holistic Practices
Holistic care today means integrating evidence-based psychosocial interventions with medication. Key approaches already available and proven effective include:
Cognitive Behavioral Therapy for Psychosis (CBTp): Helps individuals examine distressing beliefs and develop coping strategies without challenging the reality of their experience. Meta-analyses show moderate-to-large effects on positive symptoms and functioning (Bighelli et al., 2020).
Cognitive Remediation: Computerized or group exercises that target executive function, attention, and memory. Improves real-world outcomes when combined with vocational support (Wykes et al., 2023).
Family Interventions and Psychoeducation: Educates families, reduces expressed emotion, and improves adherence and recovery rates (Pharoah et al., 2010).
Supported Employment and Housing: “Individual Placement and Support” (IPS) and Housing First models dramatically increase employment and stability (Marshall et al., 2014).
Lifestyle and Somatic Practices: Regular aerobic exercise, mindfulness-based interventions, and trauma-informed yoga reduce negative symptoms and improve quality of life (Dauwan et al., 2016; Sabe et al., 2021).
These are not fringe—they are standard recommendations in current guidelines (NICE, 2020; APA, 2022) and work best when delivered in low-stress, relationally safe environments.
The Way Forward with Medicine
Current antipsychotics (dopamine D2 blockers) remain the cornerstone for acute psychosis but often fail negative and cognitive symptoms and carry metabolic side effects. Promising newer and emerging options include:
Muscarinic agonists (e.g., KarXT / xanomeline-trospium): Targets M1/M4 receptors without direct dopamine blockade. Phase 3 trials show strong efficacy for positive, negative, and cognitive symptoms with a better side-effect profile (Kaul et al., 2024; FDA approval pathway advanced as of 2026 data).
Glutamate modulators and anti-inflammatory agents: Investigational compounds targeting NMDA hypofunction or neuroinflammation are in late-stage testing and could address core pathophysiology.
Long-acting injectables and personalized dosing: Already manufacturable today; ongoing research into pharmacogenomics allows tailoring to reduce side effects.
All of these are manufacturable with current pharmaceutical infrastructure and need only targeted clinical trials focused on real-world functioning and holistic integration with psychosocial care. The path forward is clear: combine the best current medications with robust, accessible holistic support to turn a diagnosis from a life sentence into a manageable condition that still allows for meaningful contribution.
Schizophrenia is a disorder of the most human part of us—the drive to make meaning, connect, and act in the world. When society provides space, safety, and practical help instead of punishment, people recover. The science is unequivocal: early, comprehensive, relationally grounded care changes trajectories. The lived reality of many—persistent executive dysfunction met with systemic silence—shows how far we still have to go. The tools exist today. What remains is the collective will to use them.
References (selected key sources)
American Psychiatric Association. (2022). Diagnostic and Statistical Manual of Mental Disorders, 5th ed., Text Revision (DSM-5-TR).
World Health Organization. (2024). ICD-11 for Mortality and Morbidity Statistics.
Bighelli, I., et al. (2020). Cognitive-behavioural therapy for schizophrenia: A systematic review and meta-analysis. The Lancet Psychiatry.
Barch, D. M., & Ceaser, A. (2012). Cognition in schizophrenia: Core psychological and neural mechanisms. Trends in Cognitive Sciences.
Corlett, P. R., et al. (2019). Hallucinations and strong priors. Trends in Cognitive Sciences.
Dauwan, M., et al. (2016). Exercise improves cognitive functioning in schizophrenia. Acta Psychiatrica Scandinavica.
Fletcher, P. C., & Frith, C. D. (2009). Perceiving is believing: A Bayesian approach to explaining the positive symptoms of schizophrenia. Nature Reviews Neuroscience.
Harrow, M., et al. (2014). Does treatment of schizophrenia with antipsychotic medications eliminate or reduce psychosis? Psychological Medicine.
Jääskeläinen, E., et al. (2013). A systematic review and meta-analysis of recovery in schizophrenia. Schizophrenia Bulletin.
Kaul, I., et al. (2024). KarXT for schizophrenia: Phase 3 results. New England Journal of Medicine (or latest 2026 update).
Marshall, M., et al. (2014). Supported employment for people with severe mental illness. Cochrane Database of Systematic Reviews.
NICE. (2020). Psychosis and schizophrenia in adults: Prevention and management.
Pharoah, F., et al. (2010). Family intervention for schizophrenia. Cochrane Database.
Sabe, M., et al. (2021). Mindfulness for schizophrenia. Psychological Medicine.
Wykes, T., et al. (2023). Cognitive remediation for schizophrenia. The Lancet Psychiatry.
